Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) — Capital Reinvestment Ratio
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥43.77 Million) in capital expenditures (CN¥3.65 Million). Check 688505 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Capital Reinvestment Ratio (2009–2025)
This chart tracks Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 15 annual periods. For the full cash flow conversion analysis, see 688505 cash flow metrics.
Annual Capital Reinvestment Ratio for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (2009–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd from 2009 to 2025. See Shanghai Fudan-Zhangjiang Bio-Pharmaceut free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | CN¥141.40 Million | CN¥32.37 Million | ▼ -83.6% |
| 2023 | 1.39x | CN¥71.02 Million | CN¥98.97 Million | ▲ +163.8% |
| 2022 | 0.53x | CN¥165.27 Million | CN¥87.30 Million | ▲ +18.3% |
| 2021 | 0.45x | CN¥268.90 Million | CN¥120.12 Million | ▲ +19.0% |
| 2020 | 0.38x | CN¥113.00 Million | CN¥42.41 Million | ▲ +150.2% |
| 2019 | 0.15x | CN¥269.23 Million | CN¥40.39 Million | ▼ -31.0% |
| 2018 | 0.22x | CN¥173.94 Million | CN¥37.79 Million | ▼ -84.8% |
| 2017 | 1.43x | CN¥42.71 Million | CN¥60.94 Million | ▲ +328.4% |
| 2016 | 0.33x | CN¥140.57 Million | CN¥46.82 Million | ▼ -19.3% |
| 2015 | 0.41x | CN¥96.30 Million | CN¥39.75 Million | ▼ -18.8% |
| 2014 | 0.51x | CN¥88.36 Million | CN¥44.91 Million | ▼ -20.8% |
| 2013 | 0.64x | CN¥89.44 Million | CN¥57.38 Million | ▼ -38.4% |
| 2012 | 1.04x | CN¥110.19 Million | CN¥114.69 Million | ▲ +56.5% |
| 2011 | 0.67x | CN¥49.59 Million | CN¥32.99 Million | ▼ -90.8% |
| 2009 | 7.23x | CN¥7.72 Million | CN¥55.82 Million | — |